Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Furr-Stimming, Erin
CT-AMT-130-01, NCT04120493: Safety and Proof-of-Concept (POC) Study with AMT-130 in Adults with Early Manifest Huntington's Disease Jan 2021 - Dec 2021 : Early efficacy data on initial patients for Huntington's disease First biomarker data from trial for Huntington’s disease Nov 2021 - Nov 2021: First biomarker data from trial for Huntington’s disease Safety data from P1/2 trial for Huntington’s disease Feb 2021 - Feb 2021: Safety data from P1/2 trial for Huntington’s disease	Recruiting	1/2	37	US	intra-striatal rAAV5-miHTT, AMT-130, Imitation (sham) surgery	UniQure Biopharma B.V.	Huntington's Disease	04/29	06/29
vUHDRS, NCT05748288: Development of the Virtual Unified Huntington's Disease Rating Scale	Completed	N/A	60	US		Huntington Study Group	Huntington Disease	05/23	05/23
HDClarity, NCT02855476: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease	Recruiting	N/A	2500	Europe, Canada, US, RoW		University College, London, CHDI Foundation, Inc.	Huntington's Disease	05/25	05/25